Welcome to our dedicated page for Leidos Holdings news (Ticker: LDOS), a resource for investors and traders seeking the latest updates and insights on Leidos Holdings stock.
Overview of Leidos Holdings, Inc.
Leidos Holdings, Inc. (NYSE: LDOS) is a Fortune 500 technology, engineering, and science company that delivers comprehensive solutions for some of the nation's most complex challenges. Leveraging its deep expertise in defense, intelligence, and health, the company provides integrated services and innovative digital solutions that support national security, modernize critical infrastructures, and enhance health outcomes. With extensive experience partnering with U.S. government agencies and commercial entities, Leidos is at the forefront of advancing cybersecurity, digital modernization, geospatial intelligence, and mission-critical IT transformation.
Core Business Segments
Leidos organizes its operations into three primary segments, each addressing key market requirements:
- Defense Solutions: This segment supplies cutting-edge technologies and services that help secure national defense and intelligence missions. By delivering advanced cybersecurity measures, digital transformation initiatives, and secure communications, Leidos ensures that defense agencies maintain resilient infrastructures.
- Civil Sector: Focused on supporting public institutions, the Civil segment provides innovative engineering and digital services to state and local government agencies. These solutions are designed to optimize IT systems, enhance public safety, and improve operational efficiencies in heavily regulated industries.
- Health Services: In the health domain, Leidos develops and implements technology-driven solutions that enhance patient care, streamline clinical research, and support robust health infrastructures. The company collaborates with prominent health agencies to deliver managed health services and clinical innovations that drive better health outcomes.
Industry-Leading Capabilities
Leidos is recognized for its commitment to technological innovation and operational excellence. Some of the key factors that underline its industry authority include:
- Digital Modernization: Continuous integration of advanced IT systems and secure communications enhances both digital and physical infrastructure resilience.
- Cybersecurity & Data Integrity: The company delivers robust cybersecurity solutions, emphasizing secure cryptographic key management and zero trust architectures that safeguard sensitive data.
- Geospatial & Intelligence Services: Through precision geospatial intelligence and comprehensive topographic data analysis, Leidos equips government agencies with the information necessary for critical decision-making.
- Collaborative Innovation: By partnering with cutting-edge technology providers and utilizing open architecture frameworks, Leidos continuously refines its product offerings and operational strategies.
Market Position and Competitive Edge
Positioned within the competitive landscape of defense and health technology, Leidos distinguishes itself through:
- Proven Track Record: With decades of experience in supporting key government missions, Leidos has developed a reputation for reliability and technical prowess.
- Integrated Solutions: Its integrated service model across defense, civil, and health sectors ensures a holistic approach to solving complex challenges.
- Expert Workforce: The company's deep bench of technical professionals and domain experts drives innovative project delivery and enhances client trust.
Commitment to Innovation and Excellence
Leidos is dedicated to providing mission-critical solutions that not only solve today's challenges but also lay a robust foundation for ongoing technological innovation. Its strategy is built on enhancing operational efficiency, ensuring the integrity of digital infrastructures and defending national assets from emerging threats. By continuously upgrading its technology portfolio and collaborating with industry partners, Leidos remains a trusted name in delivering sophisticated solutions to complex problems.
Conclusion
The company's multi-faceted business model, extensive experience, and unwavering commitment to excellence make it a significant player in the defense, civil, and health sectors. Investors and stakeholders seeking a comprehensive understanding of a company that bridges technology with practical solutions will find Leidos Holdings, Inc. to be a prime example of enduring innovation and meticulous execution.
On August 3, 2020, Leidos announced the appointment of Elizabeth Porter as Health Group President, effective immediately. Reporting to Chairman and CEO Roger Krone, Porter will oversee a $2 billion business with 7,500 employees focused on transforming patient care and healthcare operations. She has been acting president since March 9, and her experience includes leadership roles at Lockheed Martin. Krone emphasized her strong track record in driving growth, noting her expertise will be crucial as the health market evolves.
Leidos Holdings (NYSE: LDOS) has declared a quarterly cash dividend of $0.34 per share. This dividend will be paid on September 30, 2020, to shareholders of record by September 15, 2020. Leidos, a leader in information technology and engineering solutions, reported annual revenues of approximately $11.09 billion for the fiscal year ending January 3, 2020.
Leidos (NYSE: LDOS), a leading science and technology firm, will participate in the Jefferies 2020 Virtual Industrials Conference on August 6, 2020, featuring a fireside chat led by Chairman and CEO Roger Krone at 1:15 p.m. ET. The event will be available via a live audio webcast on Leidos' Investor Relations website, with a replay accessible for 30 days post-event. Leidos reported annual revenues of approximately $11.09 billion for the fiscal year ending January 3, 2020, employing around 37,000 personnel to tackle significant challenges across various sectors.
Leidos (NYSE:LDOS) announced that 18 employees will be recognized at the 2020 Women of Color STEM conference in Detroit, marking the largest cohort in the company's history. Regina Cer and Audrey Lambert will receive the Technology Rising Star award, while others like Stephanie Alley and Rita Chavez will be honored with the Technology All-Star award. Additionally, Dr. Carol Brevett will receive the Outstanding Technical Contribution award. Leidos emphasizes its commitment to diversity and inclusion, highlighting the contributions of women in STEM fields.
Leidos (NYSE:LDOS) has secured a contract from U.S. Customs and Border Protection to implement a non-intrusive inspection system for high-energy rail infrastructure. This contract, valued at approximately $379 million, spans an ordering period of five years starting July 1, 2020. Leidos will utilize its VACIS IR6500 system, enhancing threat detection capabilities significantly. The technology aims to improve efficiency in screening $180 billion worth of rail freight annually, thereby aiding in the prevention of contraband smuggling into the U.S.
Leidos (NYSE:LDOS) has secured a task order from the U.S. Army Contracting Command valued at approximately $210 million for providing Intelligence, Electronic Warfare and Sensors (IEW&S) system and software support. The contract includes a one-year base period with four additional one-year options. The work will primarily occur at Aberdeen Proving Ground, Md. Under this contract, Leidos will enhance the reliability and interoperability of the Army's systems through its agile software development process and portfolio management dashboard.
Leidos (NYSE: LDOS) has scheduled a conference call for August 4, 2020, at 8 a.m. (ET) to discuss its second-quarter financial results for the period ending July 3, 2020. The earnings press release will precede the call on the same day. Investors can listen via the internet or telephone, and a replay will be available from 11:30 a.m. (ET) on August 4 through 11:59 p.m. (ET) on August 11, 2020. Leidos reported $11.09 billion in annual revenues for fiscal year ending January 3, 2020.
Leidos (NYSE:LDOS) has secured a prime contract with Edinburgh Airport Limited to enhance its security tray systems by implementing antimicrobial technology. This technology reduces bacteria like E. coli and MRSA by 99.99%, addressing health concerns amid the ongoing pandemic. Leidos has collaborated with Edinburgh Airport since 2012 and aims to support improved health safety for travelers. The company reported revenues of approximately $11.09 billion for the fiscal year ending January 3, 2020, and has a strong portfolio of security detection solutions deployed in over 120 countries.
Leidos (NYSE:LDOS) has secured a $79 million contract from the Department of Veterans Affairs to design and implement a regional consolidated mail outpatient pharmacy system (CMOP). The contract includes a two-year performance period with 20 additional three-month options. Leidos aims to replace the existing facility in Leavenworth, Kansas, establishing a highly automated pharmacy capable of processing over 80,000 prescriptions daily. This initiative supports the VA's modernization efforts and enhances service to U.S. military veterans.
Leidos (NYSE: LDOS) and the Baltimore Ravens are distributing nearly 70,000 drug disposal packets across Baltimore as part of the "Tackling Opioid Addiction" campaign. This initiative aims to combat the opioid epidemic, which has escalated during the COVID-19 pandemic, with over 90% of drug-related deaths in Baltimore being opioid-related. The packets will allow residents to safely dispose of leftover prescriptions at home. Leidos has maintained a commitment to addressing opioid addiction since 2017, implementing several community-driven initiatives.
FAQ
What is the current stock price of Leidos Holdings (LDOS)?
What is the market cap of Leidos Holdings (LDOS)?
What are the core business segments of Leidos Holdings?
Who are the primary customers of Leidos Holdings?
How does Leidos generate its revenue?
What sets Leidos apart from its competitors?
What kinds of technological solutions does Leidos offer?
How does Leidos support national security and health sectors?
What role does innovation play in Leidos' business model?
Does Leidos engage in strategic partnerships?
